Egészségbiztosítási Alap

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

GYED is the largest single cash line in the chapter — larger than táppénz, larger than the rokkantsági block — and it carries the earnings-replacement defect in its sharpest form. The benefit is set at 70% of the parent's prior gross income, subject to a statutory ceiling; from 1 January 2026 the maximum monthly amount is a gross 451,920 Ft. It is drawn for an extended period — up to the child's second birthday — which makes it the largest per-recipient liability of the three earnings-scaled lines. The multi-tier arithmetic makes the within-class transfer concrete. A parent who earned the minimum wage before the birth draws GYED at 70% of that minimum wage. A parent who earned at or above the ceiling draws the capped maximum — a gross 451,920 Ft a month. The two benefits differ by a wide multiple, per month, for the full run to the child's second birthday. Both are funded from the same flat-rate contribution levied on every insured wage, including the minimum-wage parent's. The minimum-wage contributor is funding, in part, the supplement that scales with the ceiling-level earner's salary. The universalist framing — "GYED supports every working parent" — describes the coverage and conceals the distribution: coverage is universal, the benefit is earnings-scaled, and an earnings-scaled benefit paid from a flat pooled levy transfers, on net, from lower earners to higher earners. This is the same financing pathology that runs through the supplementary pension supplement, the family tax credit, and every other line where a benefit scales with prior earnings while the funding is pooled — and it is worth naming the mechanism plainly because mainstream discourse, governing and opposition alike, debates GYED as a question of generosity (is the ceiling high enough, is the duration long enough) and almost never as a question of who funds whom. The reform answers the second question: fund the benefit from the recipient's own prior contributions, and the regressive cross-subsidy disappears without the income-protection function being touched.

Indoklás

This line is part of the gyógyszertámogatás (drug subsidy) block — the reimbursement of prescription medicines for insured patients, the support that brings chronic-disease and acute medication within reach at the pharmacy counter. NEAK reimburses at tiered rates depending on the therapeutic category and the severity of the indication, with the higher state-paid shares attaching to the more chronic and severe conditions. The severity-graduated structure is itself evidence that the line is functioning as protection against involuntary harm rather than as a discretionary consumption subsidy: the state-paid share rises precisely where the patient's need is least a matter of preference and most a matter of medical necessity. Reimbursement of medicines for serious and chronic illness is within the protective category. Keep. This is a Keep with a real efficiency caveat, and the caveat is large enough to name. A single state purchaser negotiating a positive list and administratively-set reimbursement tiers has no market price signal for the relative value of competing therapies; the list and the tiers are set by administrative judgement, and the manufacturer-and-distributor payments that appear on the revenue side of this same chapter are the state's attempt to claw back, through a levy, rents that the administered-pricing system itself creates. The financing of the line is Keep; the pricing mechanism is open to the ordinary value-for-money scrutiny that Keep always permits.

Indoklás

This line funds the benefits paid to people with reduced working capacity — the rokkantsági ellátás for those assessed as unable to work and the rehabilitációs ellátás for those assessed as rehabilitable. It is a large line, reaching on the order of 254,000 people following the 2024 reassessment of the qualification rules. It is tempting, given the earnings-replacement objection applied to CSED, táppénz and GYED, to reach for the same classification here. That would be a mistake, and the distinction matters. The three cash lines above replace income during a temporary, foreseeable, and in most cases voluntary or quasi-voluntary life event — a birth, a short illness, early child-rearing — for which a working person can, in principle, accumulate a funded reserve over a career. Disability is none of those things. It is an involuntary, often permanent, and frequently early-onset loss of earning capacity. A worker disabled at thirty has not had a working life over which to accumulate a self-insurance balance; the funded-account logic that fits a birth or a sick week does not fit a permanent loss of the capacity to earn at all. The framework's protective category — a response to involuntary harm whose magnitude makes it a matter of rights rather than preference — is the correct home for this line. Disability support of last resort, for people who cannot self-insure against a risk that may strike before they have earned anything, is within the class of functions the classical-liberal frame affirms. Keep. Keep does not mean immune from review. The assessment process — who is classified as rokkant, who as rehabilitable, on what evidentiary standard — is a genuine governance question, and the disability rolls of many European states have at times absorbed people who, with the right rehabilitation pathway, could re-enter work. But that is a question of assessment integrity and rehabilitation design, addressed by the qualification rules and the rehabilitation service, not by phasing out the benefit. The line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered, and the distinction is the substantive point in this chapter. Hungary finances its health system through a single state purchaser, NEAK, paying overwhelmingly state-owned providers. A single state purchaser facing state-owned providers has no market price signal for the cost, mix, or quality of care: NEAK sets tariffs administratively, capacity is allocated administratively, and the soft budget constraint characteristic of state-owned providers — losses absorbed by the centre rather than disciplining the provider — runs through the whole system. The visible symptom is the one every Hungarian household already knows: long waits in the state system, and a parallel private sector that exists precisely because the state monopoly fails on access and timeliness. Roughly a quarter of total health spending in Hungary is already out-of-pocket — well above the EU norm — and voluntary insurance and private clinics (Medicover, Affidea, Doktor24 and others) operate at scale, delivering same-week appointments against months in the state queue. The parallel private sector is the in-country demonstration that competing providers and visible prices produce faster access; Hungarian readers do not need a foreign example, because they already use one. The reform direction this chapter points at is therefore not a cut to the curative envelope — the envelope is, if anything, low for the country's needs — but a change in the purchasing architecture: separating the financing function (which stays) from state ownership of providers (which need not), allowing provider plurality so that the purchaser has a real choice and a real price, and unbundling routine care from catastrophic care so that price discovery can operate where it can and pooled protection operates where it must. That is delivery-model reform, not a transition-taxonomy reclassification, and it belongs in the whitepaper's healthcare treatment rather than in a line-item phase-out. The classification of the financing line is Keep.

Indoklás

Táppénz replaces wages during sickness absence, at 60% of the contribution base (50% for workers with shorter insurance histories or in the early days of an absence). In 2024 Hungarian workers claimed approximately 26 million calendar days of sick benefit nationally. The structural objection is identical to CSED's: this is an earnings-replacement benefit — the daily payment scales with the claimant's prior wage — financed from a flat-rate pooled levy. A higher earner's sick day is reimbursed at a higher daily rate than a lower earner's, out of contributions levied at the same rate on both. The pooled-levy-funding-an-earnings-scaled-benefit pattern produces the same within-class cross-subsidy: the diagnostic is earnings-scaled benefit plus flat-rate pooled funding plus universalist branding, and táppénz exhibits all three.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

CSED replaces income for a parent during the first 168 calendar days after a birth. It is paid at 100% of the prior daily income (70% where the parent returns to paid work after the child's first three months). This is the structural feature that the analytical frame fastens on, and it is worth being exact about it. CSED is not a flat per-child grant. It is an earnings-replacement transfer: the benefit a recipient draws is a fixed multiple of what that recipient earned before the birth. The funding, by contrast, is pooled — it comes from the szociális hozzájárulási adó and the társadalombiztosítási járulék paid by every contributor into the Fund, at a flat rate on wages. Set those two facts beside each other. A parent who earned at the top of the wage distribution before the birth draws a CSED several times larger, per day, than a parent who earned at the minimum wage — for the same event, the same 168 days, the same biological fact of a new child. The contribution that funds both is levied at the same flat rate on every insured wage. The effect is a transfer that runs, in net terms, within the working population from lower earners to higher earners: the minimum-wage contributor is part-funding the supplement that scales with the salary of the upper-decile contributor. The universalist branding — "every insured parent is covered" — is true and hides this. Coverage is universal; the benefit amount is earnings-scaled, and an earnings-scaled benefit paid out of a flat-rate pooled levy is a regressive cross-subsidy whatever it is called. The reform is not to abolish income protection around a birth. It is to change the financing mechanism so that the benefit a parent draws is funded by that parent's own prior contributions rather than by a pooled levy that makes lower earners cross-subsidise higher earners. A funded individual social-insurance account — each worker accumulates a balance from their own contributions, draws their own earnings-replacement benefit from it, with a general-revenue floor for workers whose balances are thin — preserves the income-protection function and removes the within-class transfer. The insured person still receives an earnings-related benefit; it is simply their own earnings that fund it.

Indoklás

This line is part of the gyógyszertámogatás (drug subsidy) block — the reimbursement of prescription medicines for insured patients, the support that brings chronic-disease and acute medication within reach at the pharmacy counter. NEAK reimburses at tiered rates depending on the therapeutic category and the severity of the indication, with the higher state-paid shares attaching to the more chronic and severe conditions. The severity-graduated structure is itself evidence that the line is functioning as protection against involuntary harm rather than as a discretionary consumption subsidy: the state-paid share rises precisely where the patient's need is least a matter of preference and most a matter of medical necessity. Reimbursement of medicines for serious and chronic illness is within the protective category. Keep. This is a Keep with a real efficiency caveat, and the caveat is large enough to name. A single state purchaser negotiating a positive list and administratively-set reimbursement tiers has no market price signal for the relative value of competing therapies; the list and the tiers are set by administrative judgement, and the manufacturer-and-distributor payments that appear on the revenue side of this same chapter are the state's attempt to claw back, through a levy, rents that the administered-pricing system itself creates. The financing of the line is Keep; the pricing mechanism is open to the ordinary value-for-money scrutiny that Keep always permits.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyászati segédeszköz támogatás (medical-device subsidy) block — subsidy of medical aids and devices including prosthetics, mobility aids, custom-made appliances — for insured patients. The custom-made line in particular serves people whose medical need cannot be met by an off-the-shelf product. Like the drug subsidy, this is support for the management of involuntary medical conditions rather than a discretionary consumption transfer. Keep, with the same standard caveat that the procurement and reimbursement pricing of devices is open to value-for-money review.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the cross-border and treaty-based care block — lines that fund emergency and planned care for insured Hungarians abroad and the settlement of treaty-based reciprocal-care obligations (chiefly the EU's cross-border-care framework). The sürgősségi ellátás component is emergency care — a protective response to involuntary, time-critical harm that happens not to occur on Hungarian soil. The treaty-settlement components are obligations Hungary has contracted and which bind while the treaty binds; honouring a contracted reciprocal obligation is the rule-of-law method the framework requires. Keep.

Indoklás

This line is part of the gyógyászati segédeszköz támogatás (medical-device subsidy) block — subsidy of medical aids and devices including prosthetics, mobility aids, custom-made appliances — for insured patients. The custom-made line in particular serves people whose medical need cannot be met by an off-the-shelf product. Like the drug subsidy, this is support for the management of involuntary medical conditions rather than a discretionary consumption transfer. Keep, with the same standard caveat that the procurement and reimbursement pricing of devices is open to value-for-money review.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line pays annuities for occupational accident and injury compensation. These are not discretionary transfers and not earnings-scaled social benefits in the CSED/táppénz sense; they are compensation owed for involuntary injury sustained, in most cases, in the course of insured employment — accrued, individualised claims with the character of a liability the Fund has incurred rather than a programme it chooses to run. Honouring an accrued compensation claim is the rule-of-law position the framework takes throughout. Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

The service fee paid to pharmacies for dispensing subsidised medicines — the remuneration of the dispensing function that delivers the gyógyszertámogatás line to patients. It is the transaction cost of the drug-subsidy function and follows that function's Keep classification; it cannot be removed without removing the means by which subsidised medicine reaches the patient. Keep, with pharmacy remuneration formulae open to the standard efficiency review.

Indoklás

A contingency reserve against in-kind benefit cost overruns within the curative block. A reserve takes the classification of the function it backstops; it backstops Keep curative lines, and prudent provisioning against an estimation error in a rights-relevant block is ordinary fiscal management. Keep.

Indoklás

This line is part of the egyéb, ellátásokhoz kapcsolódó kiadások (other benefit-related costs) block — the mechanical settlement costs of paying the Fund's benefits: reimbursement of employers who act as paying agents (kifizetőhely), postage on benefit payments, and residual minor costs. These are not a programme; they are the unavoidable transaction cost of operating the benefit lines, and they rise and fall with those lines. They follow the classification of the benefits they service — predominantly Keep lines — and cannot be cut independently of the function. Keep, on the same logic by which a payroll charge follows its personnel line.

Indoklás

Reimbursement of patients' travel costs to receive care. This is an access-supporting adjunct to the curative function: where the care itself is Keep, the cost of physically reaching it — for patients in rural areas or those needing care concentrated in specialist centres — is part of making the rights-relevant service genuinely available rather than nominally available. It moves with the curative block. Keep.

Indoklás

This line is part of the Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund) block — the running cost of the central organ that administers the Health Insurance Fund: the body that collects contributions, maintains the insurance register, processes claims, and pays benefits. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean. The classification of an administrative organ follows the classification of the function it administers. The Fund pays a mixture of Keep curative lines and Phase-Out earnings-replacement lines; some claims-processing, contribution-collection and register-keeping function is required whichever way the cash benefits are ultimately financed, because the curative block and the disability block remain and must be administered. The administrative organ is therefore Keep at the chapter level. If the cash-benefit financing transition runs its full course, the scale of the administrative function shifts — from administering pooled earnings-replacement benefits toward administering funded accounts and a curative purchaser — but the function does not disappear, and a 25-year transition gives ample time for the staffing mix to adjust through ordinary turnover. The employer-contribution sub-line (863.1 millió Ft) is, as in every institutional chapter, the state taxing its own administrative payroll — a transfer from the Fund's pocket to the treasury's pocket, real in the accounts but not a separately decidable cost. Keep.

Indoklás

This line is part of the egyéb, ellátásokhoz kapcsolódó kiadások (other benefit-related costs) block — the mechanical settlement costs of paying the Fund's benefits: reimbursement of employers who act as paying agents (kifizetőhely), postage on benefit payments, and residual minor costs. These are not a programme; they are the unavoidable transaction cost of operating the benefit lines, and they rise and fall with those lines. They follow the classification of the benefits they service — predominantly Keep lines — and cannot be cut independently of the function. Keep, on the same logic by which a payroll charge follows its personnel line.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the cross-border and treaty-based care block — lines that fund emergency and planned care for insured Hungarians abroad and the settlement of treaty-based reciprocal-care obligations (chiefly the EU's cross-border-care framework). The treaty-settlement components are obligations Hungary has contracted and which bind while the treaty binds; honouring a contracted reciprocal obligation is the rule-of-law method the framework requires. Keep.

Indoklás

A contingency reserve against in-kind benefit cost overruns within the curative block. A reserve takes the classification of the function it backstops; it backstops Keep curative lines, and prudent provisioning against an estimation error in a rights-relevant block is ordinary fiscal management. Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line subsidises balneological and spa treatments. It sits apart from the curative block in character: where emergency surgery and dialysis are protective responses to irreversible harm, spa therapy is at the discretionary, quality-of-life end of the spectrum, and its medical cost-effectiveness against alternatives is exactly the kind of contested, preference-laden allocation a state purchaser cannot price. There is, in addition, an established commercial market in Hungarian spa and wellness provision; the subsidised treatments compete with services consumers already buy voluntarily at a market price. The case for compulsory-contribution financing of this line is weak — it is neither rights-protection nor a response to involuntary harm — and the honest classification is a phase-out. The protected party here is not a claimant of an earnings-replacement entitlement; it is the set of spa operators delivering subsidised treatment under current arrangements, and the patients mid-course of a prescribed programme. A short linear phase-out gives operators time to re-price their offering toward the voluntary market they already serve and gives in-flight patients time to complete prescribed courses. Five years is sufficient: this is a discrete, small, commercially-substitutable subsidy, not a cohort entitlement.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund) block — the running cost of the central organ that administers the Health Insurance Fund. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean. The classification of an administrative organ follows the classification of the function it administers; the function does not disappear under the transition, and a 25-year horizon gives ample time for the staffing mix to adjust through ordinary turnover. Keep.

Indoklás

This line is part of the gyógyító-megelőző ellátás block — the financing of medical care itself, and the largest block in the chapter. These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework's protective category exists to prevent. Classified Keep as a block. Keep is a statement about whether the function is financed, not an endorsement of how it is delivered. The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification. The classification of the financing line is Keep.

Indoklás

This line is part of the Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund) block — the running cost of the central organ that administers the Health Insurance Fund. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean. The employer-contribution sub-line is, as in every institutional chapter, the state taxing its own administrative payroll — a transfer from the Fund's pocket to the treasury's pocket, real in the accounts but not a separately decidable cost. Keep.

Indoklás

A small discretionary one-off assistance line within the cash-benefit block. At 450.0 millió Ft it is immaterial to the chapter total and the cost of separately reforming it would exceed any saving. It is not an earnings-scaled entitlement and does not carry the structural defect of the three large cash lines. Hold it at nominal level; real-terms erosion at typical inflation does the bounded work.

Indoklás

This line is part of the egyéb, ellátásokhoz kapcsolódó kiadások (other benefit-related costs) block — the mechanical settlement costs of paying the Fund's benefits: reimbursement of employers who act as paying agents (kifizetőhely), postage on benefit payments, and residual minor costs. These are not a programme; they are the unavoidable transaction cost of operating the benefit lines, and they rise and fall with those lines. They follow the classification of the benefits they service — predominantly Keep lines — and cannot be cut independently of the function. Keep, on the same logic by which a payroll charge follows its personnel line.

Indoklás

This line is part of the Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund) block — the running cost of the central organ that administers the Health Insurance Fund. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean. The classification of an administrative organ follows the classification of the function it administers; the function does not disappear under the transition, and a 25-year horizon gives ample time for the staffing mix to adjust through ordinary turnover. Keep.

Indoklás

This line finances the supply of donor breast milk, in practice for premature and medically vulnerable infants who cannot otherwise be fed. At 200.0 millió Ft it is the smallest substantive line in the chapter. It is a protective response to involuntary harm to identifiable vulnerable individuals — newborns in neonatal care — with no voluntary alternative available to the infant. Keep.

Indoklás

This line is part of the Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund) block — the running cost of the central organ that administers the Health Insurance Fund. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean. The classification of an administrative organ follows the classification of the function it administers; the function does not disappear under the transition, and a 25-year horizon gives ample time for the staffing mix to adjust through ordinary turnover. Keep.

Indoklás

This line is part of the cross-border and treaty-based care block — lines that fund emergency and planned care for insured Hungarians abroad and the settlement of treaty-based reciprocal-care obligations (chiefly the EU's cross-border-care framework). The treaty-settlement components are obligations Hungary has contracted and which bind while the treaty binds; honouring a contracted reciprocal obligation is the rule-of-law method the framework requires. Keep.

Indoklás

The asset-management line of the Fund — the cost of managing the Fund's own property, against which it books a small property income. At 5.7 millió Ft of expenditure it is the smallest line in the chapter and immaterial to any total. It is the ordinary administrative cost of an insurance fund holding and managing assets; it generates more revenue than it costs. Keep.